Each year, more than eight million patients visit emergency departments in the United States with chest pain suggestive of myocardial ischemia. Yet, in around 75% of cases, objective evidence of unstable coronary syndrome is lacking after the initial clinical and ECG evaluation.
Accelerated diagnostic protocols using biochemical markers and near-patient testing strategies with the Stratus® CS analyzer can help address this challenge. Consequently, hospital stays—and the cost to manage both ACS-positive and ACS-negative patients—can be reduced.
Fast, informative results
- Rapid turnaround time: 14 minutes to first result, and 4 minutes for each subsequent result
- A broad menu of tests to support better chest pain differentiation from a single sample, on a single run, on a single instrument
Easy-to-use in the Emergency Department, Coronary Care Unit, STAT Lab or Central Lab
- Simple operation for all skill levels: load sample, rotor, TestPak™ Cartridge(s)—and press Start
- System accepts blood directly from collection tube—no sample preparation, no manual dilutions
- Integrated centrifuge spins whole blood to plasma and automatically pipettes to test cartridges—no user manipulation needed
Efficient and cost-effective
- Eliminates manual intervention steps that prolong result turnaround
- Single use packaging for tests, calibrators, and diluents reduce reagent waste
- Select tests based on patient need—no fixed assay panels
- System Check (electronic QC) reduces liquid QC frequency requirements
Compliant
- Barcode readers and lockout features for near-patient testing compliance
- Fully compliant with OSHA Bloodborne Pathogens Preamble
- First to the market with a guideline acceptable troponin I assay with the low end precision to meet the 2012 ESC/ACC Guidelines
Extensive Support
- Onsite training
- Field service group
- Technical telephone support
More Information Here